{"gene":"FOXD3","run_date":"2026-06-09T23:54:44","timeline":{"discoveries":[{"year":2002,"finding":"Foxd3 is required for maintenance of pluripotent epiblast cells in the early mouse embryo. Foxd3-/- embryos die after implantation (~E6.5) with loss of epiblast cells and expansion of extraembryonic tissues. Foxd3-/- blastocysts express Oct4, Sox2, and Fgf4 normally but inner cell mass fails to expand in vitro, and Foxd3-/- ES cell lines cannot be established. Chimera analysis shows Foxd3 function is required cell-autonomously in the epiblast.","method":"Germline knockout mouse, chimera analysis, in vitro blastocyst culture, immunofluorescence for pluripotency markers","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular phenotype, chimera rescue experiment, multiple orthogonal readouts in a single rigorous study","pmids":["12381664"],"is_preprint":false},{"year":2001,"finding":"FoxD3 is required for neural crest determination in Xenopus. Overexpression of FoxD3 in ectoderm induces neural crest markers, while a dominant-negative FoxD3 (FoxD3delN) inhibits neural crest differentiation without suppressing CNS marker Sox2. Loss-of-function phenotypes are rescued by co-injection of Slug. FoxD3 is epistatic upstream of Slug: Slug induction by Zic factors requires FoxD3-related signaling.","method":"Xenopus overexpression, dominant-negative construct (FoxD3delN), morpholino epistasis, animal cap explant assays","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain- and loss-of-function experiments with epistasis in vivo and in explants, replicated with multiple approaches","pmids":["11493569"],"is_preprint":false},{"year":1998,"finding":"Hfh2 (FOXD3) is expressed in premigratory and migrating neural crest cells in the early mouse embryo and in motor neuron progenitors of the developing spinal cord, as determined by in situ hybridization. The Hfh2 gene was mapped to mouse chromosome 4 by linkage analysis.","method":"In situ hybridization, linkage analysis","journal":"Mechanisms of development","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization by in situ hybridization in multiple embryonic tissues, single lab","pmids":["9767163"],"is_preprint":false},{"year":2006,"finding":"Zebrafish foxd3 (sym1 allele with disrupted forkhead DNA-binding domain) is selectively required for neural crest specification toward neuronal, glial, and cartilage fates but not melanocytes. sym1 mutants have normal numbers of premigratory neural crest cells but reduced snai1b and sox10 expression, implicating foxd3 as an upstream regulator of these transcription factors. Neural crest migration onset is delayed, migratory trunk neural crest cells are reduced, and TUNEL analysis reveals aberrant apoptosis in hindbrain neural crest.","method":"Zebrafish forward genetics (sym1 mutant), gene expression analysis, TUNEL apoptosis assay","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function allele with defined cellular phenotypes, multiple orthogonal readouts, epistasis placing foxd3 upstream of snai1b and sox10","pmids":["16499899"],"is_preprint":false},{"year":2008,"finding":"Foxd3 is required for self-renewal and pluripotency maintenance in mouse embryonic stem cells (ESCs). Conditional deletion of Foxd3 in ESCs causes increased apoptosis, decreased clonal self-renewal, and precocious differentiation along trophectoderm, endoderm, and mesendoderm lineages, despite continued expression of Oct4, Sox2, and Nanog. Foxd3 functions to repress differentiation and promote ESC survival independently of these core pluripotency factors.","method":"Conditional knockout (tamoxifen-inducible Cre) in ESCs, proliferation assays, apoptosis assays, clonal self-renewal assays, lineage marker analysis","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with multiple orthogonal phenotypic readouts, clean mechanistic separation from Oct4/Sox2/Nanog","pmids":["18653770"],"is_preprint":false},{"year":2010,"finding":"FOXD3 levels are upregulated in mutant B-RAF melanoma cells following attenuation of B-RAF and MEK signaling (selectively in mutant B-RAF, not wild-type B-RAF cells). Ectopic FOXD3 expression causes G1 cell cycle arrest in melanoma cells via p53-dependent upregulation of p21(Cip1); p53 depletion prevents FOXD3-induced arrest. FOXD3 does not alter ERK1/2 activation by mutant B-RAF.","method":"siRNA knockdown, ectopic overexpression, MEK inhibitor treatment, cell cycle analysis, p53/p21 depletion rescue experiments","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple loss- and gain-of-function experiments, epistasis (p53/p21 rescue), mechanistic pathway placement in single rigorous study","pmids":["20332228"],"is_preprint":false},{"year":2011,"finding":"Neural crest stem cell multipotency requires Foxd3 to maintain neural potential and repress mesenchymal fates. Conditional NC-specific Foxd3 deletion causes loss of neural NC derivatives and ectopic NC-derived vascular smooth muscle cells in the aorta, along with precocious osteoblast/chondrocyte differentiation. Individual mutant NC cells from different axial levels lose neural and gain myofibroblast potential, demonstrating that Foxd3 maintains a cell-intrinsic fate restriction.","method":"Conditional neural crest-specific knockout mouse, lineage tracing, clonal in vitro fate assays, histological and molecular analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with clonal fate assays and multiple orthogonal phenotypic readouts demonstrating cell-intrinsic requirement","pmids":["21228004"],"is_preprint":false},{"year":2011,"finding":"Upregulation of FOXD3 following B-RAF/MEK inhibitor (PLX4032/PLX4720) treatment confers resistance to cell death in mutant B-RAF melanoma cells. siRNA-mediated knockdown of FOXD3 significantly enhances cell death after PLX4032/4720 treatment. FOXD3 upregulation is attenuated in non-adherent conditions, and ectopic FOXD3 expression in non-adherent cells reduces PLX4720-induced cell death.","method":"siRNA knockdown, ectopic overexpression, pharmacological B-RAF/MEK inhibition, cell death assays, adherent vs. non-adherent culture conditions","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple loss- and gain-of-function experiments, single lab, mechanistic link between FOXD3 and drug resistance established","pmids":["21996740"],"is_preprint":false},{"year":2011,"finding":"FOXD3 inhibits migration, invasion, and spheroid outgrowth of mutant B-RAF melanoma cells. FOXD3 directly binds the Rnd3 promoter and represses Rnd3 expression at both mRNA and protein levels. Inhibition of ROCK (a downstream effector of RhoA, which Rnd3 normally inhibits) partially restores migration in FOXD3-expressing cells, placing FOXD3 upstream of Rnd3-RhoA-ROCK signaling.","method":"Ectopic overexpression, chromatin immunoprecipitation (ChIP) at Rnd3 promoter, migration/invasion assays, ROCK inhibitor rescue","journal":"Molecular cancer research : MCR","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP establishes direct promoter binding, ROCK inhibitor rescue provides epistasis, single lab","pmids":["21478267"],"is_preprint":false},{"year":2011,"finding":"tfap2a and foxd3 are jointly necessary and sufficient for neural crest induction in zebrafish. Double mutant mob;mos embryos completely lack all neural crest-derived tissues. foxd3 is expressed in dorsal mesendoderm/ectoderm during gastrulation prior to neural crest induction. foxd3 overexpression enhances tfap2a-driven ectopic neural crest induction. Loss of both genes expands Bmp signaling and suppresses canonical Wnt targets, disrupting neural crest induction domain.","method":"Zebrafish double mutant analysis, overexpression, Bmp/Wnt pathway readouts in double mutants","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — double mutant epistasis with gain-of-function validation, multiple pathway readouts, clear genetic interaction","pmids":["21963426"],"is_preprint":false},{"year":2012,"finding":"Two FoxD3 neural crest enhancers (NC1 and NC2) drive spatially and temporally distinct expression in cranial vs. vagal/trunk neural crest subpopulations. Mutational analysis, in vivo ChIP, and morpholino knockdowns reveal that Pax7 and Msx1/2 cooperate with Ets1 to bind the cranial NC1 enhancer, while at vagal/trunk levels these factors function with Zic1, which directly binds NC2. This reveals differential upstream regulation of FoxD3 across neural crest subpopulations.","method":"Enhancer reporter assays, mutational analysis of enhancer elements, in vivo ChIP, morpholino knockdown epistasis in chick/Xenopus","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vivo ChIP with mutational analysis of binding sites, epistasis by morpholino, multiple orthogonal methods","pmids":["23284303"],"is_preprint":false},{"year":2013,"finding":"Neural crest and Schwann cell progenitor-derived melanocytes are spatially segregated (epaxial vs. hypaxial domains). Both populations originate from the Foxd3 lineage but diverge at different times from Foxd3-positive progenitors. Gain- and loss-of-function experiments in avians and mice show Foxd3 is both sufficient and necessary for regulating the balance between melanocyte and Schwann cell development, and also regulates the switch between neuronal and glial fates in sensory ganglia.","method":"Lineage tracing, conditional knockout (mouse), gain-of-function (avian electroporation), loss-of-function experiments","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal gain- and loss-of-function in two species with lineage tracing, multiple fate outcomes measured","pmids":["23858437"],"is_preprint":false},{"year":2006,"finding":"FoxD3 is required for Nodal expression in the Xenopus Spemann organizer and this is essential for dorsal mesoderm formation. FoxD3 functions as a transcriptional repressor (Engrailed-FoxD3 mimics native activity; VP16-FoxD3 blocks it) to induce mesodermal genes and convergent extension. FoxD3 induces mesoderm non-cell-autonomously, consistent with induction of secreted Nodal-related factors. Nodal signaling inhibitors block FoxD3-mediated mesoderm induction.","method":"Xenopus overexpression (native, Engrailed-fusion, VP16-fusion FoxD3), morpholino knockdown, explant assays, Nodal inhibitor rescue","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple complementary constructs (gain/loss-of-function, repressor/activator fusions), non-cell-autonomous rescue, epistasis with Nodal inhibitors","pmids":["17092955"],"is_preprint":false},{"year":2007,"finding":"HDAC1 (colgate/hdac1) represses foxd3 expression in zebrafish neural crest to permit mitfa-dependent melanogenesis. In hdac1 mutants, foxd3 expression is elevated and mitfa-positive melanoblasts are severely reduced. Partial reduction of Foxd3 in hdac1 mutants rescues mitfa expression and melanophore defects. Foxd3 physically interacts with the mitfa promoter, demonstrating that Foxd3 directly represses mitfa transcription.","method":"Zebrafish hdac1 mutant analysis, morpholino knockdown of foxd3, chromatin association assay at mitfa promoter","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis (hdac1 mutant + foxd3 MO rescue), direct promoter interaction demonstrated, placed in HDAC1→Foxd3⊣Mitfa pathway","pmids":["18068699"],"is_preprint":false},{"year":2010,"finding":"In zebrafish neural crest, Foxd3 and Mitf regulate a bi-potent pigment precursor fate decision: Foxd3 suppresses mitfa to promote iridophore development, while Mitfa promotes melanophore fate. Loss of foxd3 causes fewer iridophores; loss of mitfa causes supernumerary iridophores. Double foxd3;mitfa mutants restore iridophore numbers. Foxd3 co-localizes with pnp4a (novel iridophore marker) and is necessary for its expression. Cell lineage analysis with EosFP shows both melanophores and iridophores derive from a mitfa+ precursor.","method":"Zebrafish single and double mutant analysis, in situ hybridization, photoconvertible lineage tracing (EosFP), genetic epistasis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — double mutant epistasis combined with cell lineage tracing, multiple orthogonal methods establishing Foxd3/Mitfa transcriptional switch","pmids":["20460180"],"is_preprint":false},{"year":2009,"finding":"Disc1 functions upstream of foxd3 and sox10 in zebrafish cranial neural crest (CNC): loss of Disc1 results in persistent CNC cell medial migration and enhanced expression of foxd3 and sox10. General CNC cell motility (speed) is unaffected. Disc1 is proposed to function in transcriptional repression of foxd3 and sox10, mediating CNC migration and differentiation.","method":"Zebrafish morpholino knockdown of disc1, live imaging of CNC migration, in situ hybridization for foxd3 and sox10","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — morpholino knockdown with migration tracking and expression readouts, single lab; places disc1 upstream of foxd3","pmids":["19570850"],"is_preprint":false},{"year":2006,"finding":"Foxd3 directly transactivates the myf5 promoter by interacting with the -82/-62 cassette element, as identified by yeast one-hybrid assay and confirmed by dual-luciferase reporter assay. Morpholino knockdown of foxd3 dramatically reduces myf5 expression in somites and adaxial cells (but not presomitic mesoderm), without affecting myod. Pax3 acts upstream of foxd3 to maintain myf5 expression; foxd3 mRNA rescues myf5 expression in pax3 morphants.","method":"Yeast one-hybrid assay, dual-luciferase reporter assay, zebrafish morpholino knockdown, mRNA rescue experiment","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast one-hybrid plus luciferase for direct DNA binding, morpholino epistasis in vivo, single lab","pmids":["16386728"],"is_preprint":false},{"year":2010,"finding":"Foxd3 and Pax3 genetically interact in cardiac neural crest (NC) development. NC-specific homozygous Foxd3 deletion combined with Pax3 heterozygosity causes fully penetrant persistent truncus arteriosus, severe thymus hypoplasia, increased NC cell death in neural folds, and near-complete absence of NC caudal to pharyngeal arch 1 — phenotypes absent in single mutants. This gene dosage-sensitive interaction demonstrates Foxd3 and Pax3 act together to maintain cardiac NC progenitor survival.","method":"Conditional NC-specific Foxd3 knockout combined with Pax3 heterozygous knockout (compound mutant), histology, apoptosis assays","journal":"Genesis (New York, N.Y. : 2000)","confidence":"High","confidence_rationale":"Tier 2 / Strong — compound mutant genetic interaction with fully penetrant phenotype, mechanistically informative dosage sensitivity","pmids":["21254333"],"is_preprint":false},{"year":2013,"finding":"FOXD3 directly binds the NDRG1 promoter to activate its transcription in neuroblastoma cells, as shown by luciferase reporter and chromatin immunoprecipitation assays. FOXD3 overexpression suppresses growth, invasion, metastasis, and angiogenesis of neuroblastoma cells in vitro and in vivo; FOXD3 knockdown promotes these properties. Rescue experiments show that NDRG1 restoration prevents FOXD3-mediated changes, and that FOXD3 acts through NDRG1 to regulate VEGF and MMP9.","method":"Luciferase reporter assay, ChIP, siRNA knockdown, ectopic overexpression, xenograft tumor model, rescue experiments with NDRG1 restoration","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and luciferase confirm direct binding, rescue experiment places FOXD3 upstream of NDRG1, single lab","pmids":["24269992"],"is_preprint":false},{"year":2014,"finding":"FOXD3 directly binds the promoter of miR-137 and activates its transcription in hepatocellular carcinoma (HCC) cells. miR-137 targets AKT2, and FOXD3-regulated miR-137 inhibits HCC growth and metastasis via suppression of the AKT2/mTOR pathway. In vivo studies confirm the FoxD3/miR-137/AKT2 regulatory network.","method":"Luciferase reporter assay, ChIP at miR-137 promoter, overexpression/knockdown, AKT2 rescue experiments, xenograft model","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and luciferase establish direct promoter binding, epistasis rescue experiment, single lab","pmids":["24970808"],"is_preprint":false},{"year":2016,"finding":"FOXD3 acts as a dual-function regulator of enhancer activity in pluripotent cells: it recruits the SWI/SNF chromatin remodeling ATPase BRG1 to promote nucleosome removal (enhancer priming/opening) while simultaneously recruiting histone deacetylases HDAC1/2 to inhibit maximal enhancer activation. FOXD3 binds distinct enhancer sites in ESCs vs. epiblast stem cells (EpiSCs), modulating developmental potential as cells differentiate from naive to primed pluripotency.","method":"ChIP-seq, ATAC-seq/chromatin accessibility assays, co-immunoprecipitation for BRG1 and HDAC1/2, conditional Foxd3 deletion in ESCs and EpiSCs","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP-seq plus co-IP identifying BRG1 and HDAC1/2 as co-factors, conditional KO, multiple orthogonal chromatin and functional assays","pmids":["26748757"],"is_preprint":false},{"year":2016,"finding":"Foxd3 promotes exit from naive pluripotency by decommissioning active enhancers associated with naive pluripotency and early germline genes. As a repressor, Foxd3 dismantles a significant fraction of the naive pluripotency expression program during the ESC-to-EpiSC transition. Subsequently, Foxd3 must itself be silenced in primed pluripotent cells to allow re-activation of genes required for primordial germ cell (PGC) specification.","method":"Conditional Foxd3 knockout, ChIP-seq for enhancer marks (H3K27ac), RNA-seq, genome-wide chromatin analysis comparing ESC and EpiSC states","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — genome-wide ChIP-seq and RNA-seq combined with conditional KO; multiple orthogonal methods in single rigorous study","pmids":["26748758"],"is_preprint":false},{"year":2015,"finding":"PAX3 and FOXD3 cooperate to drive CXCR4 expression in melanoma cells through a conserved intronic enhancer element. Inhibition of PAX3 and FOXD3 reduces CXCR4 expression, slows cell growth and migration, and decreases chemotaxis; these effects are rescued by CXCR4 overexpression. Overexpression of PAX3 and FOXD3 drives increased CXCR4 levels.","method":"siRNA knockdown, overexpression, enhancer reporter assays, migration/invasion/chemotaxis assays, CXCR4 rescue experiments","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — enhancer reporter plus gain/loss-of-function with CXCR4 rescue establishing epistasis, single lab","pmids":["26205821"],"is_preprint":false},{"year":2013,"finding":"Foxd3 conditional deletion in mouse embryonic stem cells causes misregulation of genes involved in embryonic organ development, epithelium development, and epithelial differentiation. Six novel transcriptional targets of Foxd3 were identified: Sox4, Safb, Sox15, Fosb, Pmaip1, and Smarcd3. Data suggest Foxd3 functions upstream of genes required for skeletal muscle development.","method":"Conditional Foxd3 deletion, microarray gene expression analysis, identification of downstream targets","journal":"Stem cell research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — conditional KO with genome-wide expression profiling, novel targets identified but direct binding not confirmed for all, single lab","pmids":["24270162"],"is_preprint":false},{"year":2016,"finding":"CHD7, Oct3/4, Sox2, and Nanog directly occupy multiple conserved regions (mE1, mE2, mE3) of the mouse FoxD3 locus in a BMP2/Wnt3a-dependent manner to induce FoxD3 expression during neural crest-derived stem cell (NCSC) formation. FoxD3 in turn promotes Sox10 expression required for NCSC formation. Histone H3K4 mono- or trimethylation is also required at the FoxD3 locus.","method":"ChIP assay at FoxD3 regulatory regions, siRNA knockdown of CHD7/Oct3/4/Sox2/Nanog, histone methyltransferase inhibition","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirms direct occupancy of FoxD3 locus by multiple factors, siRNA epistasis, single lab","pmids":["27579714"],"is_preprint":false},{"year":2016,"finding":"FOXD3 is validated as a transcription factor that directly binds the miR-214 promoter (by ChIP assay) in colorectal cancer (CRC) cells, activating miR-214 expression. miR-214 targets MED19. The FOXD3/miR-214/MED19 axis mediates inhibition of proliferation, invasion, and metastasis in CRC in vitro and in vivo.","method":"ChIP assay at miR-214 promoter, dual-luciferase reporter for MED19 targeting, overexpression/knockdown, xenograft model","journal":"British journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirms FOXD3 binding at miR-214 promoter, luciferase confirms MED19 as target, single lab","pmids":["27811858"],"is_preprint":false},{"year":2017,"finding":"FOXD3 knockdown in colon cancer cells activates the EGFR/Ras/Raf/MEK/ERK pathway, increases proliferation, invasion, and inhibits apoptosis; these effects are reversed by EGFR blocking. FOXD3 functions as a transcriptional repressor that suppresses EGFR-Ras-Raf-MEK-ERK signaling in colon cancer.","method":"siRNA knockdown, ectopic overexpression, pharmacological EGFR inhibition, xenograft model, Western blotting for pathway components","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — loss-of-function with pathway readouts and EGFR inhibitor rescue providing pathway placement, single lab","pmids":["27926503"],"is_preprint":false},{"year":2020,"finding":"FOXD3 regulates VISTA (V-domain Ig suppressor of T cell activation) expression in melanoma cells at the transcript level. BRAF inhibition upregulates FOXD3 and concurrently reduces VISTA expression. Tumor cell-specific VISTA expression promotes tumor onset in vivo, associated with increased intratumoral T regulatory cells and enhanced PDL-1 on tumor-infiltrating macrophages.","method":"siRNA knockdown, BRAF inhibitor treatment, in vivo tumor growth assay, flow cytometry for immune infiltrate","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — FOXD3 knockdown/BRAF inhibition modulates VISTA, in vivo validation, single lab; direct promoter binding not demonstrated","pmids":["31940493"],"is_preprint":false}],"current_model":"FOXD3 (also known as Genesis/HFH2) is a forkhead/winged-helix transcription factor that functions primarily as a transcriptional repressor and context-dependent activator: it maintains pluripotency and self-renewal in epiblast and embryonic stem cells by repressing differentiation programs (acting through BRG1-mediated chromatin remodeling and HDAC1/2 recruitment to prime-then-silence enhancers); specifies and maintains multipotent neural crest progenitors by suppressing mesenchymal fates and regulating downstream transcription factors including Slug, Sox10, Snai1b, and Mitfa (whose promoter FOXD3 directly occupies); induces mesodermal development in Xenopus via non-cell-autonomous induction of Nodal-related secreted signals; and in differentiated cancer contexts, is suppressed by mutant B-RAF–MEK signaling in melanoma, with its re-expression causing p53/p21-dependent G1 arrest, downregulation of Rnd3 (suppressing migration via RhoA-ROCK), and regulation of VISTA, CXCR4, VEGF, and other downstream targets through direct promoter binding."},"narrative":{"mechanistic_narrative":"FOXD3 is a forkhead/winged-helix transcription factor that acts predominantly as a context-dependent transcriptional repressor to maintain progenitor and pluripotent states and to restrict premature differentiation [PMID:12381664, PMID:18653770, PMID:17092955]. In the early embryo it is required cell-autonomously for maintenance of pluripotent epiblast and for embryonic stem cell self-renewal and survival, functioning independently of Oct4, Sox2, and Nanog to suppress differentiation programs [PMID:12381664, PMID:18653770]. At the chromatin level FOXD3 operates as a dual-function enhancer regulator, recruiting the SWI/SNF ATPase BRG1 to open nucleosomes while simultaneously recruiting HDAC1/2 to limit enhancer activation, and during the transition from naive to primed pluripotency it decommissions naive and germline enhancers, after which FOXD3 must itself be silenced to license primordial germ cell specification [PMID:26748757, PMID:26748758]. FOXD3 is a core regulator of neural crest specification and multipotency: it is induced at the neural crest locus by CHD7/Oct3/4/Sox2/Nanog in a BMP/Wnt-dependent manner and through Pax7/Msx1-2/Ets1 and Zic1 enhancer inputs, acts jointly with tfap2a for neural crest induction, and lies genetically upstream of Slug, snai1b, and sox10 to maintain neural potential and survival while repressing mesenchymal and pigment-cell fates [PMID:11493569, PMID:16499899, PMID:21228004, PMID:21963426, PMID:23284303, PMID:27579714]. It directly represses the mitfa promoter to govern the melanophore-versus-iridophore and melanocyte-versus-Schwann-cell fate decisions [PMID:18068699, PMID:20460180, PMID:23858437], and acts non-cell-autonomously in the Xenopus organizer to induce Nodal-related signals and dorsal mesoderm [PMID:17092955]. In cancer, FOXD3 is re-induced upon attenuation of mutant B-RAF/MEK signaling in melanoma, where it drives p53/p21-dependent G1 arrest, represses the Rnd3-RhoA-ROCK migration axis through direct promoter binding, and confers tolerance to BRAF/MEK inhibitors [PMID:20332228, PMID:21996740, PMID:21478267]; across other carcinomas it functions as a tumor suppressor through direct promoter activation of targets such as NDRG1, miR-137, and miR-214 and repression of EGFR-Ras-MEK-ERK signaling [PMID:24269992, PMID:24970808, PMID:27811858, PMID:27926503].","teleology":[{"year":1998,"claim":"Established where FOXD3 acts in the embryo by mapping its expression to premigratory/migrating neural crest and motor neuron progenitors, framing it as a candidate neural crest regulator.","evidence":"In situ hybridization and linkage mapping in mouse embryo","pmids":["9767163"],"confidence":"Medium","gaps":["Expression alone does not establish function","No direct targets or binding sites defined"]},{"year":2001,"claim":"Demonstrated FOXD3 is necessary and sufficient for neural crest determination and acts upstream of Slug, defining its position in the neural crest gene regulatory hierarchy.","evidence":"Xenopus gain/loss-of-function, dominant-negative construct, and Slug rescue epistasis","pmids":["11493569"],"confidence":"High","gaps":["Direct DNA targets not identified","Molecular mechanism of repression vs activation not resolved"]},{"year":2002,"claim":"Showed FOXD3 is required cell-autonomously for pluripotent epiblast maintenance, separating its role from initiation of the Oct4/Sox2 pluripotency program.","evidence":"Germline knockout mouse with chimera analysis and blastocyst culture","pmids":["12381664"],"confidence":"High","gaps":["Downstream effectors of survival/self-renewal unknown","Mechanism of repression at chromatin not addressed"]},{"year":2006,"claim":"Defined FOXD3 as a transcriptional repressor that non-cell-autonomously induces mesoderm via Nodal-related signals, and as a direct transactivator of myf5, revealing context-dependent activator/repressor behavior.","evidence":"Xenopus repressor/activator fusion constructs with Nodal-inhibitor rescue; yeast one-hybrid plus luciferase and zebrafish morpholino epistasis for myf5","pmids":["17092955","16386728"],"confidence":"High","gaps":["Co-factors mediating repressor vs activator switch not identified","Direct Nodal-related target promoters not mapped"]},{"year":2006,"claim":"Placed foxd3 upstream of snai1b and sox10 in neural crest specification while showing fate-selective requirement (neuronal/glial/cartilage but not melanocyte), refining its lineage-specific roles.","evidence":"Zebrafish forward-genetic sym1 mutant with expression analysis and TUNEL","pmids":["16499899"],"confidence":"High","gaps":["Direct vs indirect regulation of snai1b/sox10 not distinguished","Cause of lineage-selective apoptosis unresolved"]},{"year":2007,"claim":"Identified mitfa as a direct repression target and embedded FOXD3 in an HDAC1→Foxd3⊣Mitfa pathway controlling melanogenesis.","evidence":"Zebrafish hdac1 mutant with foxd3 morpholino rescue and chromatin association at the mitfa promoter","pmids":["18068699"],"confidence":"High","gaps":["Co-repressor complex at mitfa promoter not defined","Mechanism of HDAC1 repression of foxd3 not detailed"]},{"year":2008,"claim":"Distinguished FOXD3's ESC self-renewal/survival function from the core pluripotency factors, showing it represses differentiation and promotes survival independently of Oct4/Sox2/Nanog.","evidence":"Tamoxifen-inducible conditional knockout in ESCs with apoptosis, clonal self-renewal, and lineage marker assays","pmids":["18653770"],"confidence":"High","gaps":["Direct survival/differentiation target genes not yet identified","Chromatin mechanism not addressed"]},{"year":2009,"claim":"Positioned Disc1 upstream of foxd3/sox10 in cranial neural crest migration, extending the regulatory inputs controlling FOXD3 levels.","evidence":"Zebrafish disc1 morpholino with live migration imaging and in situ hybridization","pmids":["19570850"],"confidence":"Medium","gaps":["Direct vs indirect repression of foxd3 by Disc1 not shown","Single-lab morpholino approach"]},{"year":2010,"claim":"Established FOXD3 re-expression as a tumor-suppressive output of B-RAF/MEK inhibition in melanoma, causing p53/p21-dependent G1 arrest.","evidence":"siRNA, ectopic expression, MEK inhibitor treatment, and p53/p21 depletion rescue in mutant B-RAF melanoma cells","pmids":["20332228"],"confidence":"High","gaps":["Direct FOXD3 targets driving p21 induction not mapped","How B-RAF/MEK suppresses FOXD3 not resolved"]},{"year":2010,"claim":"Defined a Foxd3/Mitfa transcriptional switch governing the bi-potent melanophore/iridophore fate decision from a common mitfa+ precursor.","evidence":"Zebrafish single/double mutant epistasis with photoconvertible EosFP lineage tracing","pmids":["20460180"],"confidence":"High","gaps":["Direct iridophore-program targets beyond pnp4a not defined","Cofactors for fate switch unknown"]},{"year":2011,"claim":"Showed Foxd3 maintains cell-intrinsic neural crest multipotency by repressing mesenchymal/skeletal fates, and dissected its anti-migratory mechanism via direct repression of Rnd3-RhoA-ROCK in melanoma.","evidence":"Conditional NC-specific KO with clonal fate assays (mouse); ChIP at Rnd3 promoter with ROCK-inhibitor rescue (melanoma)","pmids":["21228004","21478267"],"confidence":"High","gaps":["Direct mesenchymal-repression targets in NC not fully mapped","Rnd3 work is single-lab Medium-confidence"]},{"year":2011,"claim":"Demonstrated tfap2a and foxd3 are jointly necessary and sufficient for neural crest induction via modulation of Bmp/Wnt signaling, and that FOXD3 upregulation confers BRAF-inhibitor tolerance in melanoma.","evidence":"Zebrafish double-mutant analysis with pathway readouts; siRNA/overexpression with PLX4032/4720 cell-death assays in melanoma","pmids":["21963426","21996740"],"confidence":"High","gaps":["Mechanism by which FOXD3 promotes drug tolerance not defined","Direct Bmp/Wnt-pathway targets unknown"]},{"year":2011,"claim":"Showed Foxd3 and Pax3 cooperate in a dosage-sensitive manner for cardiac neural crest progenitor survival, defining a genetic partnership.","evidence":"Compound conditional Foxd3 KO with Pax3 heterozygosity, histology and apoptosis assays in mouse","pmids":["21254333"],"confidence":"High","gaps":["Molecular basis of Foxd3-Pax3 cooperation (physical vs genetic) not established","Shared survival target genes unknown"]},{"year":2012,"claim":"Mapped the upstream enhancer logic controlling FoxD3 across neural crest subpopulations, showing distinct Pax7/Msx1-2/Ets1 (cranial NC1) and Zic1 (vagal/trunk NC2) inputs.","evidence":"Enhancer reporters, mutational analysis, in vivo ChIP, and morpholino epistasis in chick/Xenopus","pmids":["23284303"],"confidence":"High","gaps":["How distinct enhancer usage maps to functional output not resolved","FOXD3's own targets in these subpopulations not addressed"]},{"year":2013,"claim":"Demonstrated Foxd3 controls melanocyte-vs-Schwann-cell and neuron-vs-glia fate switches, and acts as a context-dependent tumor suppressor in neuroblastoma via direct NDRG1 activation.","evidence":"Avian/mouse gain- and loss-of-function with lineage tracing; luciferase, ChIP, knockdown, and xenograft with NDRG1 rescue in neuroblastoma","pmids":["23858437","24269992","24270162"],"confidence":"High","gaps":["Direct binding for many ESC microarray targets unconfirmed","NDRG1 work single-lab Medium-confidence"]},{"year":2016,"claim":"Resolved the chromatin mechanism: FOXD3 dually recruits BRG1 (enhancer opening) and HDAC1/2 (activation restraint), and decommissions naive/germline enhancers to drive exit from naive pluripotency before being silenced for PGC specification.","evidence":"ChIP-seq, ATAC-seq, co-IP for BRG1 and HDAC1/2, RNA-seq, and conditional KO in ESCs and EpiSCs","pmids":["26748757","26748758"],"confidence":"High","gaps":["What dictates priming vs silencing at a given enhancer not fully defined","Determinants of ESC vs EpiSC binding-site selection unknown"]},{"year":2016,"claim":"Mapped the regulatory network controlling and downstream of FoxD3 in neural crest stem cell formation, with CHD7/Oct3/4/Sox2/Nanog inducing FoxD3 in a BMP/Wnt-dependent manner and FoxD3 promoting Sox10.","evidence":"ChIP at FoxD3 regulatory regions, siRNA knockdown, and histone methyltransferase inhibition","pmids":["27579714"],"confidence":"Medium","gaps":["Direct FoxD3 occupancy at Sox10 not shown here","Single-lab study"]},{"year":2017,"claim":"Extended FOXD3's tumor-suppressive repressor role to direct activation of miR-137 (AKT2/mTOR) and miR-214 (MED19) and suppression of EGFR-Ras-MEK-ERK in carcinomas.","evidence":"ChIP/luciferase, knockdown/overexpression, EGFR inhibitor rescue, and xenografts in HCC, CRC, and colon cancer","pmids":["24970808","27811858","27926503"],"confidence":"Medium","gaps":["Each axis established in a single lab/cancer type","Whether these reflect a unified mechanism vs context-specific outputs unclear"]},{"year":2020,"claim":"Linked FOXD3 to immune evasion by showing it regulates VISTA expression, with BRAF inhibition raising FOXD3 and lowering VISTA.","evidence":"siRNA, BRAF inhibitor treatment, in vivo tumor growth, and flow cytometry of immune infiltrate in melanoma","pmids":["31940493"],"confidence":"Medium","gaps":["Direct FOXD3 binding at the VISTA promoter not demonstrated","Single-lab study"]},{"year":null,"claim":"It remains unknown how a single forkhead factor selects between repressing, priming, and activating distinct enhancers/promoters across pluripotency, neural crest, and cancer contexts, and which cofactors dictate this switch genome-wide.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model of cofactor-determined activator/repressor switching","Determinants of cell-type-specific binding-site selection unresolved","Direct human disease-causing mutation not identified in the corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,12,20,21,13,18,25]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[8,13,16,18,25,10]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[20]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[20,13,8]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,3,6,9,11,12]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[13,16,18,20,25]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[20,21]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[5,7,8,18,26,27]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[5]}],"complexes":[],"partners":["BRG1","HDAC1","HDAC2","PAX3","TFAP2A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UJU5","full_name":"Forkhead box protein D3","aliases":["HNF3/FH transcription factor genesis"],"length_aa":478,"mass_kda":47.6,"function":"Binds to the consensus sequence 5'-A[AT]T[AG]TTTGTTT-3' and acts as a transcriptional repressor (PubMed:11891324). Also acts as a transcriptional activator (PubMed:11891324). Negatively regulates transcription of transcriptional repressor RHIT/ZNF205 (PubMed:22306510). Promotes development of neural crest cells from neural tube progenitors (PubMed:11891324). Restricts neural progenitor cells to the neural crest lineage while suppressing interneuron differentiation (PubMed:11891324). Required for maintenance of pluripotent cells in the pre-implantation and peri-implantation stages of embryogenesis (PubMed:11891324)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9UJU5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FOXD3","classification":"Not Classified","n_dependent_lines":18,"n_total_lines":1208,"dependency_fraction":0.014900662251655629},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FOXD3","total_profiled":1310},"omim":[{"mim_id":"619720","title":"BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1","url":"https://www.omim.org/entry/619720"},{"mim_id":"619399","title":"TETRASPANIN 18; TSPAN18","url":"https://www.omim.org/entry/619399"},{"mim_id":"618100","title":"MPV17 MITOCHONDRIAL INNER MEMBRANE PROTEIN-LIKE; MPV17L","url":"https://www.omim.org/entry/618100"},{"mim_id":"611539","title":"FORKHEAD BOX D3; FOXD3","url":"https://www.omim.org/entry/611539"},{"mim_id":"608160","title":"SRY-BOX 9; SOX9","url":"https://www.omim.org/entry/608160"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"intestine","ntpm":4.9}],"url":"https://www.proteinatlas.org/search/FOXD3"},"hgnc":{"alias_symbol":["Genesis","HFH2"],"prev_symbol":[]},"alphafold":{"accession":"Q9UJU5","domains":[{"cath_id":"1.10.10.10","chopping":"139-243","consensus_level":"high","plddt":84.7004,"start":139,"end":243}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UJU5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UJU5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UJU5-F1-predicted_aligned_error_v6.png","plddt_mean":55.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FOXD3","jax_strain_url":"https://www.jax.org/strain/search?query=FOXD3"},"sequence":{"accession":"Q9UJU5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UJU5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UJU5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UJU5"}},"corpus_meta":[{"pmid":"11283700","id":"PMC_11283700","title":"To err (meiotically) is human: the genesis of human aneuploidy.","date":"2001","source":"Nature reviews. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11283700","citation_count":1832,"is_preprint":false},{"pmid":"19550425","id":"PMC_19550425","title":"Apoptosis and cancer: the genesis of a research field.","date":"2009","source":"Nature reviews. Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19550425","citation_count":580,"is_preprint":false},{"pmid":"19776209","id":"PMC_19776209","title":"The mammalian ovary from genesis to revelation.","date":"2009","source":"Endocrine reviews","url":"https://pubmed.ncbi.nlm.nih.gov/19776209","citation_count":567,"is_preprint":false},{"pmid":"12040171","id":"PMC_12040171","title":"Specialized DNA polymerases, cellular survival, and the genesis of mutations.","date":"2002","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12040171","citation_count":359,"is_preprint":false},{"pmid":"16341069","id":"PMC_16341069","title":"The genesis and evolution of homeobox gene clusters.","date":"2005","source":"Nature reviews. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16341069","citation_count":350,"is_preprint":false},{"pmid":"15975993","id":"PMC_15975993","title":"Inflammation in the genesis and perpetuation of atrial fibrillation.","date":"2005","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/15975993","citation_count":349,"is_preprint":false},{"pmid":"20944665","id":"PMC_20944665","title":"The genesis and evolution of high-grade serous ovarian cancer.","date":"2010","source":"Nature reviews. Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20944665","citation_count":332,"is_preprint":false},{"pmid":"15164429","id":"PMC_15164429","title":"Timing and topography of cell genesis in the rat retina.","date":"2004","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15164429","citation_count":311,"is_preprint":false},{"pmid":"17804764","id":"PMC_17804764","title":"MicroRNA expression is required for pancreatic islet cell genesis in the mouse.","date":"2007","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/17804764","citation_count":294,"is_preprint":false},{"pmid":"15454629","id":"PMC_15454629","title":"Cell signaling and the genesis of neuropathic pain.","date":"2004","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/15454629","citation_count":279,"is_preprint":false},{"pmid":"12381664","id":"PMC_12381664","title":"Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12381664","citation_count":263,"is_preprint":false},{"pmid":"11493569","id":"PMC_11493569","title":"Requirement of FoxD3-class signaling for neural crest determination in Xenopus.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11493569","citation_count":217,"is_preprint":false},{"pmid":"15956766","id":"PMC_15956766","title":"Genesis of alcohol-induced craniofacial dysmorphism.","date":"2005","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/15956766","citation_count":182,"is_preprint":false},{"pmid":"26335954","id":"PMC_26335954","title":"Inflammation and its genesis in cystic fibrosis.","date":"2015","source":"Pediatric pulmonology","url":"https://pubmed.ncbi.nlm.nih.gov/26335954","citation_count":153,"is_preprint":false},{"pmid":"16499899","id":"PMC_16499899","title":"Zebrafish foxd3 is selectively required for neural crest specification, migration and survival.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16499899","citation_count":151,"is_preprint":false},{"pmid":"22030549","id":"PMC_22030549","title":"Perivascular instruction of cell genesis and fate in the adult brain.","date":"2011","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22030549","citation_count":127,"is_preprint":false},{"pmid":"20460180","id":"PMC_20460180","title":"Interplay between Foxd3 and Mitf regulates cell fate plasticity in the zebrafish neural crest.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20460180","citation_count":127,"is_preprint":false},{"pmid":"24789824","id":"PMC_24789824","title":"The genesis of tyrosine phosphorylation.","date":"2014","source":"Cold Spring Harbor perspectives in biology","url":"https://pubmed.ncbi.nlm.nih.gov/24789824","citation_count":124,"is_preprint":false},{"pmid":"19396957","id":"PMC_19396957","title":"Genesis, effects and fates of repeats in prokaryotic genomes.","date":"2009","source":"FEMS microbiology reviews","url":"https://pubmed.ncbi.nlm.nih.gov/19396957","citation_count":123,"is_preprint":false},{"pmid":"23284303","id":"PMC_23284303","title":"Dynamic and differential regulation of stem cell factor FoxD3 in the neural crest is Encrypted in the genome.","date":"2012","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23284303","citation_count":118,"is_preprint":false},{"pmid":"28693893","id":"PMC_28693893","title":"Emerging role for dysregulated decidualization in the genesis of preeclampsia.","date":"2017","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/28693893","citation_count":117,"is_preprint":false},{"pmid":"22802289","id":"PMC_22802289","title":"Genesis of the myofibroblast in lung injury and fibrosis.","date":"2012","source":"Proceedings of the American Thoracic Society","url":"https://pubmed.ncbi.nlm.nih.gov/22802289","citation_count":108,"is_preprint":false},{"pmid":"19629449","id":"PMC_19629449","title":"Role of cannabis and endocannabinoids in the genesis of schizophrenia.","date":"2009","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19629449","citation_count":108,"is_preprint":false},{"pmid":"1309718","id":"PMC_1309718","title":"Epinephrine and the genesis of hypertension.","date":"1992","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/1309718","citation_count":104,"is_preprint":false},{"pmid":"6450683","id":"PMC_6450683","title":"Meiosis and ascospore genesis in Neurospora.","date":"1980","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/6450683","citation_count":103,"is_preprint":false},{"pmid":"24970808","id":"PMC_24970808","title":"FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/24970808","citation_count":99,"is_preprint":false},{"pmid":"23858437","id":"PMC_23858437","title":"Neural crest and Schwann cell progenitor-derived melanocytes are two spatially segregated populations similarly regulated by Foxd3.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23858437","citation_count":96,"is_preprint":false},{"pmid":"9767163","id":"PMC_9767163","title":"The winged helix transcription factor Hfh2 is expressed in neural crest and spinal cord during mouse development.","date":"1998","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9767163","citation_count":94,"is_preprint":false},{"pmid":"19633665","id":"PMC_19633665","title":"The genesis of cerebellar interneurons and the prevention of neural DNA damage require XRCC1.","date":"2009","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19633665","citation_count":94,"is_preprint":false},{"pmid":"21228004","id":"PMC_21228004","title":"Neural crest stem cell multipotency requires Foxd3 to maintain neural potential and repress mesenchymal fates.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21228004","citation_count":93,"is_preprint":false},{"pmid":"9407626","id":"PMC_9407626","title":"Molecular changes during the genesis of human gliomas.","date":"1998","source":"Seminars in surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/9407626","citation_count":91,"is_preprint":false},{"pmid":"21963426","id":"PMC_21963426","title":"Tfap2a and Foxd3 regulate early steps in the development of the neural crest progenitor population.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21963426","citation_count":88,"is_preprint":false},{"pmid":"16549717","id":"PMC_16549717","title":"Sex hormones and the genesis of autoimmunity.","date":"2006","source":"Archives of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/16549717","citation_count":87,"is_preprint":false},{"pmid":"34349258","id":"PMC_34349258","title":"Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34349258","citation_count":86,"is_preprint":false},{"pmid":"30659874","id":"PMC_30659874","title":"The genesis and evolution of bead-based multiplexing.","date":"2019","source":"Methods (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/30659874","citation_count":86,"is_preprint":false},{"pmid":"18653770","id":"PMC_18653770","title":"Regulation of embryonic stem cell self-renewal and pluripotency by Foxd3.","date":"2008","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/18653770","citation_count":86,"is_preprint":false},{"pmid":"31969891","id":"PMC_31969891","title":"Singlet Oxygen Metabolism: From Genesis to Signaling.","date":"2020","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/31969891","citation_count":83,"is_preprint":false},{"pmid":"33526371","id":"PMC_33526371","title":"The Retromer Complex: From Genesis to Revelations.","date":"2021","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33526371","citation_count":82,"is_preprint":false},{"pmid":"26748757","id":"PMC_26748757","title":"FOXD3 Regulates Pluripotent Stem Cell Potential by Simultaneously Initiating and Repressing Enhancer Activity.","date":"2016","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/26748757","citation_count":80,"is_preprint":false},{"pmid":"25172830","id":"PMC_25172830","title":"Genesis and morphogenesis of limb synovial joints and articular cartilage.","date":"2014","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/25172830","citation_count":79,"is_preprint":false},{"pmid":"2198037","id":"PMC_2198037","title":"The genesis of alcoholic brain tissue injury.","date":"1990","source":"Alcohol and alcoholism (Oxford, Oxfordshire)","url":"https://pubmed.ncbi.nlm.nih.gov/2198037","citation_count":79,"is_preprint":false},{"pmid":"30830899","id":"PMC_30830899","title":"Genesis of the αβ T-cell receptor.","date":"2019","source":"PLoS computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/30830899","citation_count":74,"is_preprint":false},{"pmid":"20332228","id":"PMC_20332228","title":"FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.","date":"2010","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20332228","citation_count":74,"is_preprint":false},{"pmid":"12942362","id":"PMC_12942362","title":"Genesis and pathogenesis of lymphatic vessels.","date":"2003","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/12942362","citation_count":73,"is_preprint":false},{"pmid":"21147195","id":"PMC_21147195","title":"Mitochondrial protein import and the genesis of steroidogenic mitochondria.","date":"2010","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21147195","citation_count":73,"is_preprint":false},{"pmid":"19570850","id":"PMC_19570850","title":"Disc1 regulates foxd3 and sox10 expression, affecting neural crest migration and differentiation.","date":"2009","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19570850","citation_count":71,"is_preprint":false},{"pmid":"31940493","id":"PMC_31940493","title":"FOXD3 Regulates VISTA Expression in Melanoma.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31940493","citation_count":70,"is_preprint":false},{"pmid":"26748758","id":"PMC_26748758","title":"Foxd3 Promotes Exit from Naive Pluripotency through Enhancer Decommissioning and Inhibits Germline Specification.","date":"2016","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/26748758","citation_count":68,"is_preprint":false},{"pmid":"26115781","id":"PMC_26115781","title":"Plant cutin genesis: unanswered questions.","date":"2015","source":"Trends in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/26115781","citation_count":67,"is_preprint":false},{"pmid":"18068699","id":"PMC_18068699","title":"colgate/hdac1 Repression of foxd3 expression is required to permit mitfa-dependent melanogenesis.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18068699","citation_count":64,"is_preprint":false},{"pmid":"24269992","id":"PMC_24269992","title":"FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma.","date":"2013","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/24269992","citation_count":63,"is_preprint":false},{"pmid":"14598366","id":"PMC_14598366","title":"Slow axonal transport and the genesis of neuronal morphology.","date":"2004","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/14598366","citation_count":62,"is_preprint":false},{"pmid":"33498529","id":"PMC_33498529","title":"Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33498529","citation_count":61,"is_preprint":false},{"pmid":"28655711","id":"PMC_28655711","title":"Long noncoding RNA FOXD3-AS1 regulates oxidative stress-induced apoptosis via sponging microRNA-150.","date":"2017","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/28655711","citation_count":60,"is_preprint":false},{"pmid":"29398485","id":"PMC_29398485","title":"Retracted: Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF.","date":"2017","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29398485","citation_count":58,"is_preprint":false},{"pmid":"24411700","id":"PMC_24411700","title":"Physiological protein aggregation run amuck: stress granules and the genesis of neurodegenerative disease.","date":"2014","source":"Discovery medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24411700","citation_count":57,"is_preprint":false},{"pmid":"31541886","id":"PMC_31541886","title":"LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31541886","citation_count":57,"is_preprint":false},{"pmid":"37339578","id":"PMC_37339578","title":"The genesis of human hematopoietic stem cells.","date":"2023","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/37339578","citation_count":56,"is_preprint":false},{"pmid":"21996740","id":"PMC_21996740","title":"Adaptive upregulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cells.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/21996740","citation_count":55,"is_preprint":false},{"pmid":"26635811","id":"PMC_26635811","title":"Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis.","date":"2015","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26635811","citation_count":55,"is_preprint":false},{"pmid":"34605863","id":"PMC_34605863","title":"Exosomal lncRNA FOXD3-AS1 upregulates ELAVL1 expression and activates PI3K/Akt pathway to enhance lung cancer cell proliferation, invasion, and 5-fluorouracil resistance.","date":"2021","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/34605863","citation_count":53,"is_preprint":false},{"pmid":"27660268","id":"PMC_27660268","title":"Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.","date":"2016","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/27660268","citation_count":51,"is_preprint":false},{"pmid":"27926503","id":"PMC_27926503","title":"FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27926503","citation_count":49,"is_preprint":false},{"pmid":"25993993","id":"PMC_25993993","title":"A Place at the Table: LTD as a Mediator of Memory Genesis.","date":"2015","source":"The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25993993","citation_count":47,"is_preprint":false},{"pmid":"24920186","id":"PMC_24920186","title":"Using zebrafish to study podocyte genesis during kidney development and regeneration.","date":"2014","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/24920186","citation_count":47,"is_preprint":false},{"pmid":"8102106","id":"PMC_8102106","title":"The role of gene mutations in the genesis of familial cancers.","date":"1993","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/8102106","citation_count":46,"is_preprint":false},{"pmid":"11945123","id":"PMC_11945123","title":"Schizophrenia: genesis, receptorology and current therapeutics.","date":"2002","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11945123","citation_count":45,"is_preprint":false},{"pmid":"17092955","id":"PMC_17092955","title":"FoxD3 regulation of Nodal in the Spemann organizer is essential for Xenopus dorsal mesoderm development.","date":"2006","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17092955","citation_count":44,"is_preprint":false},{"pmid":"27811858","id":"PMC_27811858","title":"The FOXD3/miR-214/MED19 axis suppresses tumour growth and metastasis in human colorectal cancer.","date":"2016","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27811858","citation_count":40,"is_preprint":false},{"pmid":"33571665","id":"PMC_33571665","title":"Role of inflammatory cytokines in genesis and treatment of atherosclerosis.","date":"2021","source":"Trends in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33571665","citation_count":40,"is_preprint":false},{"pmid":"21478267","id":"PMC_21478267","title":"FOXD3 regulates migration properties and Rnd3 expression in melanoma cells.","date":"2011","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/21478267","citation_count":39,"is_preprint":false},{"pmid":"20104601","id":"PMC_20104601","title":"Genesis of teratogen-induced holoprosencephaly in mice.","date":"2010","source":"American journal of medical genetics. Part C, Seminars in medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20104601","citation_count":39,"is_preprint":false},{"pmid":"16386728","id":"PMC_16386728","title":"Foxd3 mediates zebrafish myf5 expression during early somitogenesis.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16386728","citation_count":39,"is_preprint":false},{"pmid":"30987631","id":"PMC_30987631","title":"Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer.","date":"2019","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/30987631","citation_count":38,"is_preprint":false},{"pmid":"8931090","id":"PMC_8931090","title":"Spatiotemporal gradients of cell genesis in the primate retina.","date":"1996","source":"Perspectives on developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/8931090","citation_count":38,"is_preprint":false},{"pmid":"2942331","id":"PMC_2942331","title":"Platelet and vessel wall interaction and the genesis of atherosclerosis.","date":"1986","source":"Clinics in haematology","url":"https://pubmed.ncbi.nlm.nih.gov/2942331","citation_count":36,"is_preprint":false},{"pmid":"33068927","id":"PMC_33068927","title":"LncRNA FOXD3-AS1 knockdown protects against cerebral ischemia/reperfusion injury via miR-765/BCL2L13 axis.","date":"2020","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/33068927","citation_count":35,"is_preprint":false},{"pmid":"28167050","id":"PMC_28167050","title":"Changing mutational and adaptive landscapes and the genesis of cancer.","date":"2017","source":"Biochimica et biophysica acta. Reviews on cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28167050","citation_count":34,"is_preprint":false},{"pmid":"19631262","id":"PMC_19631262","title":"Retrotransposons, reverse transcriptase and the genesis of new genetic information.","date":"2009","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/19631262","citation_count":34,"is_preprint":false},{"pmid":"11761437","id":"PMC_11761437","title":"Genesis of pituitary adenomas: state of the art.","date":"2001","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/11761437","citation_count":33,"is_preprint":false},{"pmid":"37294111","id":"PMC_37294111","title":"Genesis of clinical and subclinical endometritis in dairy cows.","date":"2023","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37294111","citation_count":32,"is_preprint":false},{"pmid":"1097980","id":"PMC_1097980","title":"Genesis and genetics of retinoblastoma.","date":"1975","source":"Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde","url":"https://pubmed.ncbi.nlm.nih.gov/1097980","citation_count":32,"is_preprint":false},{"pmid":"33782712","id":"PMC_33782712","title":"Genetic control of retinal ganglion cell genesis.","date":"2021","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/33782712","citation_count":31,"is_preprint":false},{"pmid":"32742197","id":"PMC_32742197","title":"LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/32742197","citation_count":31,"is_preprint":false},{"pmid":"35359410","id":"PMC_35359410","title":"The Subventricular Zone in Glioblastoma: Genesis, Maintenance, and Modeling.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35359410","citation_count":30,"is_preprint":false},{"pmid":"27865628","id":"PMC_27865628","title":"The genesis and presentation of anxiety in disorders of autonomic overexcitation.","date":"2016","source":"Autonomic neuroscience : basic & clinical","url":"https://pubmed.ncbi.nlm.nih.gov/27865628","citation_count":30,"is_preprint":false},{"pmid":"31632535","id":"PMC_31632535","title":"Long non-coding RNA FOXD3-AS1 aggravates ischemia/reperfusion injury of cardiomyocytes through promoting autophagy.","date":"2019","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/31632535","citation_count":30,"is_preprint":false},{"pmid":"32743522","id":"PMC_32743522","title":"Immune-mediated genesis of multiple sclerosis.","date":"2020","source":"Journal of translational autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/32743522","citation_count":29,"is_preprint":false},{"pmid":"24479800","id":"PMC_24479800","title":"Oncogenic microRNAs in the genesis of leukemia and lymphoma.","date":"2014","source":"Current pharmaceutical design","url":"https://pubmed.ncbi.nlm.nih.gov/24479800","citation_count":28,"is_preprint":false},{"pmid":"31017311","id":"PMC_31017311","title":"lncRNA FOXD3-AS1 is associated with clinical progression and regulates cell migration and invasion in breast cancer.","date":"2019","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/31017311","citation_count":26,"is_preprint":false},{"pmid":"21912849","id":"PMC_21912849","title":"Novel concepts in the genesis of hypertension: role of LOX-1.","date":"2011","source":"Cardiovascular drugs and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/21912849","citation_count":26,"is_preprint":false},{"pmid":"23178582","id":"PMC_23178582","title":"The role of stem cells and progenitors in the genesis of medulloblastoma.","date":"2012","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23178582","citation_count":25,"is_preprint":false},{"pmid":"34270934","id":"PMC_34270934","title":"Fractalkine signaling regulates oligodendroglial cell genesis from SVZ precursor cells.","date":"2021","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34270934","citation_count":25,"is_preprint":false},{"pmid":"27579714","id":"PMC_27579714","title":"CHD7, Oct3/4, Sox2, and Nanog control FoxD3 expression during mouse neural crest-derived stem cell formation.","date":"2016","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/27579714","citation_count":25,"is_preprint":false},{"pmid":"26341266","id":"PMC_26341266","title":"FOXD3 suppresses tumor growth and angiogenesis in non-small cell lung cancer.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26341266","citation_count":24,"is_preprint":false},{"pmid":"33706104","id":"PMC_33706104","title":"MiR-328-3p inhibits lung adenocarcinoma-genesis by downregulation PYCR1.","date":"2021","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/33706104","citation_count":23,"is_preprint":false},{"pmid":"26205821","id":"PMC_26205821","title":"PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26205821","citation_count":22,"is_preprint":false},{"pmid":"19568590","id":"PMC_19568590","title":"Promoter methylation in the genesis of gastrointestinal cancer.","date":"2009","source":"Yonsei medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19568590","citation_count":22,"is_preprint":false},{"pmid":"24270162","id":"PMC_24270162","title":"Transcriptional targets of Foxd3 in murine ES cells.","date":"2013","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/24270162","citation_count":22,"is_preprint":false},{"pmid":"21254333","id":"PMC_21254333","title":"Functional interaction between Foxd3 and Pax3 in cardiac neural crest development.","date":"2010","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/21254333","citation_count":22,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43447,"output_tokens":7861,"usd":0.124128,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17400,"output_tokens":5864,"usd":0.1168,"stage2_stop_reason":"end_turn"},"total_usd":0.240928,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"Foxd3 is required for maintenance of pluripotent epiblast cells in the early mouse embryo. Foxd3-/- embryos die after implantation (~E6.5) with loss of epiblast cells and expansion of extraembryonic tissues. Foxd3-/- blastocysts express Oct4, Sox2, and Fgf4 normally but inner cell mass fails to expand in vitro, and Foxd3-/- ES cell lines cannot be established. Chimera analysis shows Foxd3 function is required cell-autonomously in the epiblast.\",\n      \"method\": \"Germline knockout mouse, chimera analysis, in vitro blastocyst culture, immunofluorescence for pluripotency markers\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular phenotype, chimera rescue experiment, multiple orthogonal readouts in a single rigorous study\",\n      \"pmids\": [\"12381664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"FoxD3 is required for neural crest determination in Xenopus. Overexpression of FoxD3 in ectoderm induces neural crest markers, while a dominant-negative FoxD3 (FoxD3delN) inhibits neural crest differentiation without suppressing CNS marker Sox2. Loss-of-function phenotypes are rescued by co-injection of Slug. FoxD3 is epistatic upstream of Slug: Slug induction by Zic factors requires FoxD3-related signaling.\",\n      \"method\": \"Xenopus overexpression, dominant-negative construct (FoxD3delN), morpholino epistasis, animal cap explant assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain- and loss-of-function experiments with epistasis in vivo and in explants, replicated with multiple approaches\",\n      \"pmids\": [\"11493569\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Hfh2 (FOXD3) is expressed in premigratory and migrating neural crest cells in the early mouse embryo and in motor neuron progenitors of the developing spinal cord, as determined by in situ hybridization. The Hfh2 gene was mapped to mouse chromosome 4 by linkage analysis.\",\n      \"method\": \"In situ hybridization, linkage analysis\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization by in situ hybridization in multiple embryonic tissues, single lab\",\n      \"pmids\": [\"9767163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Zebrafish foxd3 (sym1 allele with disrupted forkhead DNA-binding domain) is selectively required for neural crest specification toward neuronal, glial, and cartilage fates but not melanocytes. sym1 mutants have normal numbers of premigratory neural crest cells but reduced snai1b and sox10 expression, implicating foxd3 as an upstream regulator of these transcription factors. Neural crest migration onset is delayed, migratory trunk neural crest cells are reduced, and TUNEL analysis reveals aberrant apoptosis in hindbrain neural crest.\",\n      \"method\": \"Zebrafish forward genetics (sym1 mutant), gene expression analysis, TUNEL apoptosis assay\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function allele with defined cellular phenotypes, multiple orthogonal readouts, epistasis placing foxd3 upstream of snai1b and sox10\",\n      \"pmids\": [\"16499899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Foxd3 is required for self-renewal and pluripotency maintenance in mouse embryonic stem cells (ESCs). Conditional deletion of Foxd3 in ESCs causes increased apoptosis, decreased clonal self-renewal, and precocious differentiation along trophectoderm, endoderm, and mesendoderm lineages, despite continued expression of Oct4, Sox2, and Nanog. Foxd3 functions to repress differentiation and promote ESC survival independently of these core pluripotency factors.\",\n      \"method\": \"Conditional knockout (tamoxifen-inducible Cre) in ESCs, proliferation assays, apoptosis assays, clonal self-renewal assays, lineage marker analysis\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with multiple orthogonal phenotypic readouts, clean mechanistic separation from Oct4/Sox2/Nanog\",\n      \"pmids\": [\"18653770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"FOXD3 levels are upregulated in mutant B-RAF melanoma cells following attenuation of B-RAF and MEK signaling (selectively in mutant B-RAF, not wild-type B-RAF cells). Ectopic FOXD3 expression causes G1 cell cycle arrest in melanoma cells via p53-dependent upregulation of p21(Cip1); p53 depletion prevents FOXD3-induced arrest. FOXD3 does not alter ERK1/2 activation by mutant B-RAF.\",\n      \"method\": \"siRNA knockdown, ectopic overexpression, MEK inhibitor treatment, cell cycle analysis, p53/p21 depletion rescue experiments\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple loss- and gain-of-function experiments, epistasis (p53/p21 rescue), mechanistic pathway placement in single rigorous study\",\n      \"pmids\": [\"20332228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Neural crest stem cell multipotency requires Foxd3 to maintain neural potential and repress mesenchymal fates. Conditional NC-specific Foxd3 deletion causes loss of neural NC derivatives and ectopic NC-derived vascular smooth muscle cells in the aorta, along with precocious osteoblast/chondrocyte differentiation. Individual mutant NC cells from different axial levels lose neural and gain myofibroblast potential, demonstrating that Foxd3 maintains a cell-intrinsic fate restriction.\",\n      \"method\": \"Conditional neural crest-specific knockout mouse, lineage tracing, clonal in vitro fate assays, histological and molecular analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with clonal fate assays and multiple orthogonal phenotypic readouts demonstrating cell-intrinsic requirement\",\n      \"pmids\": [\"21228004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Upregulation of FOXD3 following B-RAF/MEK inhibitor (PLX4032/PLX4720) treatment confers resistance to cell death in mutant B-RAF melanoma cells. siRNA-mediated knockdown of FOXD3 significantly enhances cell death after PLX4032/4720 treatment. FOXD3 upregulation is attenuated in non-adherent conditions, and ectopic FOXD3 expression in non-adherent cells reduces PLX4720-induced cell death.\",\n      \"method\": \"siRNA knockdown, ectopic overexpression, pharmacological B-RAF/MEK inhibition, cell death assays, adherent vs. non-adherent culture conditions\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple loss- and gain-of-function experiments, single lab, mechanistic link between FOXD3 and drug resistance established\",\n      \"pmids\": [\"21996740\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"FOXD3 inhibits migration, invasion, and spheroid outgrowth of mutant B-RAF melanoma cells. FOXD3 directly binds the Rnd3 promoter and represses Rnd3 expression at both mRNA and protein levels. Inhibition of ROCK (a downstream effector of RhoA, which Rnd3 normally inhibits) partially restores migration in FOXD3-expressing cells, placing FOXD3 upstream of Rnd3-RhoA-ROCK signaling.\",\n      \"method\": \"Ectopic overexpression, chromatin immunoprecipitation (ChIP) at Rnd3 promoter, migration/invasion assays, ROCK inhibitor rescue\",\n      \"journal\": \"Molecular cancer research : MCR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP establishes direct promoter binding, ROCK inhibitor rescue provides epistasis, single lab\",\n      \"pmids\": [\"21478267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"tfap2a and foxd3 are jointly necessary and sufficient for neural crest induction in zebrafish. Double mutant mob;mos embryos completely lack all neural crest-derived tissues. foxd3 is expressed in dorsal mesendoderm/ectoderm during gastrulation prior to neural crest induction. foxd3 overexpression enhances tfap2a-driven ectopic neural crest induction. Loss of both genes expands Bmp signaling and suppresses canonical Wnt targets, disrupting neural crest induction domain.\",\n      \"method\": \"Zebrafish double mutant analysis, overexpression, Bmp/Wnt pathway readouts in double mutants\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double mutant epistasis with gain-of-function validation, multiple pathway readouts, clear genetic interaction\",\n      \"pmids\": [\"21963426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Two FoxD3 neural crest enhancers (NC1 and NC2) drive spatially and temporally distinct expression in cranial vs. vagal/trunk neural crest subpopulations. Mutational analysis, in vivo ChIP, and morpholino knockdowns reveal that Pax7 and Msx1/2 cooperate with Ets1 to bind the cranial NC1 enhancer, while at vagal/trunk levels these factors function with Zic1, which directly binds NC2. This reveals differential upstream regulation of FoxD3 across neural crest subpopulations.\",\n      \"method\": \"Enhancer reporter assays, mutational analysis of enhancer elements, in vivo ChIP, morpholino knockdown epistasis in chick/Xenopus\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vivo ChIP with mutational analysis of binding sites, epistasis by morpholino, multiple orthogonal methods\",\n      \"pmids\": [\"23284303\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Neural crest and Schwann cell progenitor-derived melanocytes are spatially segregated (epaxial vs. hypaxial domains). Both populations originate from the Foxd3 lineage but diverge at different times from Foxd3-positive progenitors. Gain- and loss-of-function experiments in avians and mice show Foxd3 is both sufficient and necessary for regulating the balance between melanocyte and Schwann cell development, and also regulates the switch between neuronal and glial fates in sensory ganglia.\",\n      \"method\": \"Lineage tracing, conditional knockout (mouse), gain-of-function (avian electroporation), loss-of-function experiments\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal gain- and loss-of-function in two species with lineage tracing, multiple fate outcomes measured\",\n      \"pmids\": [\"23858437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"FoxD3 is required for Nodal expression in the Xenopus Spemann organizer and this is essential for dorsal mesoderm formation. FoxD3 functions as a transcriptional repressor (Engrailed-FoxD3 mimics native activity; VP16-FoxD3 blocks it) to induce mesodermal genes and convergent extension. FoxD3 induces mesoderm non-cell-autonomously, consistent with induction of secreted Nodal-related factors. Nodal signaling inhibitors block FoxD3-mediated mesoderm induction.\",\n      \"method\": \"Xenopus overexpression (native, Engrailed-fusion, VP16-fusion FoxD3), morpholino knockdown, explant assays, Nodal inhibitor rescue\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple complementary constructs (gain/loss-of-function, repressor/activator fusions), non-cell-autonomous rescue, epistasis with Nodal inhibitors\",\n      \"pmids\": [\"17092955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HDAC1 (colgate/hdac1) represses foxd3 expression in zebrafish neural crest to permit mitfa-dependent melanogenesis. In hdac1 mutants, foxd3 expression is elevated and mitfa-positive melanoblasts are severely reduced. Partial reduction of Foxd3 in hdac1 mutants rescues mitfa expression and melanophore defects. Foxd3 physically interacts with the mitfa promoter, demonstrating that Foxd3 directly represses mitfa transcription.\",\n      \"method\": \"Zebrafish hdac1 mutant analysis, morpholino knockdown of foxd3, chromatin association assay at mitfa promoter\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis (hdac1 mutant + foxd3 MO rescue), direct promoter interaction demonstrated, placed in HDAC1→Foxd3⊣Mitfa pathway\",\n      \"pmids\": [\"18068699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In zebrafish neural crest, Foxd3 and Mitf regulate a bi-potent pigment precursor fate decision: Foxd3 suppresses mitfa to promote iridophore development, while Mitfa promotes melanophore fate. Loss of foxd3 causes fewer iridophores; loss of mitfa causes supernumerary iridophores. Double foxd3;mitfa mutants restore iridophore numbers. Foxd3 co-localizes with pnp4a (novel iridophore marker) and is necessary for its expression. Cell lineage analysis with EosFP shows both melanophores and iridophores derive from a mitfa+ precursor.\",\n      \"method\": \"Zebrafish single and double mutant analysis, in situ hybridization, photoconvertible lineage tracing (EosFP), genetic epistasis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double mutant epistasis combined with cell lineage tracing, multiple orthogonal methods establishing Foxd3/Mitfa transcriptional switch\",\n      \"pmids\": [\"20460180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Disc1 functions upstream of foxd3 and sox10 in zebrafish cranial neural crest (CNC): loss of Disc1 results in persistent CNC cell medial migration and enhanced expression of foxd3 and sox10. General CNC cell motility (speed) is unaffected. Disc1 is proposed to function in transcriptional repression of foxd3 and sox10, mediating CNC migration and differentiation.\",\n      \"method\": \"Zebrafish morpholino knockdown of disc1, live imaging of CNC migration, in situ hybridization for foxd3 and sox10\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — morpholino knockdown with migration tracking and expression readouts, single lab; places disc1 upstream of foxd3\",\n      \"pmids\": [\"19570850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Foxd3 directly transactivates the myf5 promoter by interacting with the -82/-62 cassette element, as identified by yeast one-hybrid assay and confirmed by dual-luciferase reporter assay. Morpholino knockdown of foxd3 dramatically reduces myf5 expression in somites and adaxial cells (but not presomitic mesoderm), without affecting myod. Pax3 acts upstream of foxd3 to maintain myf5 expression; foxd3 mRNA rescues myf5 expression in pax3 morphants.\",\n      \"method\": \"Yeast one-hybrid assay, dual-luciferase reporter assay, zebrafish morpholino knockdown, mRNA rescue experiment\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast one-hybrid plus luciferase for direct DNA binding, morpholino epistasis in vivo, single lab\",\n      \"pmids\": [\"16386728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Foxd3 and Pax3 genetically interact in cardiac neural crest (NC) development. NC-specific homozygous Foxd3 deletion combined with Pax3 heterozygosity causes fully penetrant persistent truncus arteriosus, severe thymus hypoplasia, increased NC cell death in neural folds, and near-complete absence of NC caudal to pharyngeal arch 1 — phenotypes absent in single mutants. This gene dosage-sensitive interaction demonstrates Foxd3 and Pax3 act together to maintain cardiac NC progenitor survival.\",\n      \"method\": \"Conditional NC-specific Foxd3 knockout combined with Pax3 heterozygous knockout (compound mutant), histology, apoptosis assays\",\n      \"journal\": \"Genesis (New York, N.Y. : 2000)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — compound mutant genetic interaction with fully penetrant phenotype, mechanistically informative dosage sensitivity\",\n      \"pmids\": [\"21254333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"FOXD3 directly binds the NDRG1 promoter to activate its transcription in neuroblastoma cells, as shown by luciferase reporter and chromatin immunoprecipitation assays. FOXD3 overexpression suppresses growth, invasion, metastasis, and angiogenesis of neuroblastoma cells in vitro and in vivo; FOXD3 knockdown promotes these properties. Rescue experiments show that NDRG1 restoration prevents FOXD3-mediated changes, and that FOXD3 acts through NDRG1 to regulate VEGF and MMP9.\",\n      \"method\": \"Luciferase reporter assay, ChIP, siRNA knockdown, ectopic overexpression, xenograft tumor model, rescue experiments with NDRG1 restoration\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and luciferase confirm direct binding, rescue experiment places FOXD3 upstream of NDRG1, single lab\",\n      \"pmids\": [\"24269992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FOXD3 directly binds the promoter of miR-137 and activates its transcription in hepatocellular carcinoma (HCC) cells. miR-137 targets AKT2, and FOXD3-regulated miR-137 inhibits HCC growth and metastasis via suppression of the AKT2/mTOR pathway. In vivo studies confirm the FoxD3/miR-137/AKT2 regulatory network.\",\n      \"method\": \"Luciferase reporter assay, ChIP at miR-137 promoter, overexpression/knockdown, AKT2 rescue experiments, xenograft model\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and luciferase establish direct promoter binding, epistasis rescue experiment, single lab\",\n      \"pmids\": [\"24970808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"FOXD3 acts as a dual-function regulator of enhancer activity in pluripotent cells: it recruits the SWI/SNF chromatin remodeling ATPase BRG1 to promote nucleosome removal (enhancer priming/opening) while simultaneously recruiting histone deacetylases HDAC1/2 to inhibit maximal enhancer activation. FOXD3 binds distinct enhancer sites in ESCs vs. epiblast stem cells (EpiSCs), modulating developmental potential as cells differentiate from naive to primed pluripotency.\",\n      \"method\": \"ChIP-seq, ATAC-seq/chromatin accessibility assays, co-immunoprecipitation for BRG1 and HDAC1/2, conditional Foxd3 deletion in ESCs and EpiSCs\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP-seq plus co-IP identifying BRG1 and HDAC1/2 as co-factors, conditional KO, multiple orthogonal chromatin and functional assays\",\n      \"pmids\": [\"26748757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Foxd3 promotes exit from naive pluripotency by decommissioning active enhancers associated with naive pluripotency and early germline genes. As a repressor, Foxd3 dismantles a significant fraction of the naive pluripotency expression program during the ESC-to-EpiSC transition. Subsequently, Foxd3 must itself be silenced in primed pluripotent cells to allow re-activation of genes required for primordial germ cell (PGC) specification.\",\n      \"method\": \"Conditional Foxd3 knockout, ChIP-seq for enhancer marks (H3K27ac), RNA-seq, genome-wide chromatin analysis comparing ESC and EpiSC states\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — genome-wide ChIP-seq and RNA-seq combined with conditional KO; multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"26748758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PAX3 and FOXD3 cooperate to drive CXCR4 expression in melanoma cells through a conserved intronic enhancer element. Inhibition of PAX3 and FOXD3 reduces CXCR4 expression, slows cell growth and migration, and decreases chemotaxis; these effects are rescued by CXCR4 overexpression. Overexpression of PAX3 and FOXD3 drives increased CXCR4 levels.\",\n      \"method\": \"siRNA knockdown, overexpression, enhancer reporter assays, migration/invasion/chemotaxis assays, CXCR4 rescue experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — enhancer reporter plus gain/loss-of-function with CXCR4 rescue establishing epistasis, single lab\",\n      \"pmids\": [\"26205821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Foxd3 conditional deletion in mouse embryonic stem cells causes misregulation of genes involved in embryonic organ development, epithelium development, and epithelial differentiation. Six novel transcriptional targets of Foxd3 were identified: Sox4, Safb, Sox15, Fosb, Pmaip1, and Smarcd3. Data suggest Foxd3 functions upstream of genes required for skeletal muscle development.\",\n      \"method\": \"Conditional Foxd3 deletion, microarray gene expression analysis, identification of downstream targets\",\n      \"journal\": \"Stem cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — conditional KO with genome-wide expression profiling, novel targets identified but direct binding not confirmed for all, single lab\",\n      \"pmids\": [\"24270162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CHD7, Oct3/4, Sox2, and Nanog directly occupy multiple conserved regions (mE1, mE2, mE3) of the mouse FoxD3 locus in a BMP2/Wnt3a-dependent manner to induce FoxD3 expression during neural crest-derived stem cell (NCSC) formation. FoxD3 in turn promotes Sox10 expression required for NCSC formation. Histone H3K4 mono- or trimethylation is also required at the FoxD3 locus.\",\n      \"method\": \"ChIP assay at FoxD3 regulatory regions, siRNA knockdown of CHD7/Oct3/4/Sox2/Nanog, histone methyltransferase inhibition\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirms direct occupancy of FoxD3 locus by multiple factors, siRNA epistasis, single lab\",\n      \"pmids\": [\"27579714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"FOXD3 is validated as a transcription factor that directly binds the miR-214 promoter (by ChIP assay) in colorectal cancer (CRC) cells, activating miR-214 expression. miR-214 targets MED19. The FOXD3/miR-214/MED19 axis mediates inhibition of proliferation, invasion, and metastasis in CRC in vitro and in vivo.\",\n      \"method\": \"ChIP assay at miR-214 promoter, dual-luciferase reporter for MED19 targeting, overexpression/knockdown, xenograft model\",\n      \"journal\": \"British journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirms FOXD3 binding at miR-214 promoter, luciferase confirms MED19 as target, single lab\",\n      \"pmids\": [\"27811858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FOXD3 knockdown in colon cancer cells activates the EGFR/Ras/Raf/MEK/ERK pathway, increases proliferation, invasion, and inhibits apoptosis; these effects are reversed by EGFR blocking. FOXD3 functions as a transcriptional repressor that suppresses EGFR-Ras-Raf-MEK-ERK signaling in colon cancer.\",\n      \"method\": \"siRNA knockdown, ectopic overexpression, pharmacological EGFR inhibition, xenograft model, Western blotting for pathway components\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — loss-of-function with pathway readouts and EGFR inhibitor rescue providing pathway placement, single lab\",\n      \"pmids\": [\"27926503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"FOXD3 regulates VISTA (V-domain Ig suppressor of T cell activation) expression in melanoma cells at the transcript level. BRAF inhibition upregulates FOXD3 and concurrently reduces VISTA expression. Tumor cell-specific VISTA expression promotes tumor onset in vivo, associated with increased intratumoral T regulatory cells and enhanced PDL-1 on tumor-infiltrating macrophages.\",\n      \"method\": \"siRNA knockdown, BRAF inhibitor treatment, in vivo tumor growth assay, flow cytometry for immune infiltrate\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — FOXD3 knockdown/BRAF inhibition modulates VISTA, in vivo validation, single lab; direct promoter binding not demonstrated\",\n      \"pmids\": [\"31940493\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FOXD3 (also known as Genesis/HFH2) is a forkhead/winged-helix transcription factor that functions primarily as a transcriptional repressor and context-dependent activator: it maintains pluripotency and self-renewal in epiblast and embryonic stem cells by repressing differentiation programs (acting through BRG1-mediated chromatin remodeling and HDAC1/2 recruitment to prime-then-silence enhancers); specifies and maintains multipotent neural crest progenitors by suppressing mesenchymal fates and regulating downstream transcription factors including Slug, Sox10, Snai1b, and Mitfa (whose promoter FOXD3 directly occupies); induces mesodermal development in Xenopus via non-cell-autonomous induction of Nodal-related secreted signals; and in differentiated cancer contexts, is suppressed by mutant B-RAF–MEK signaling in melanoma, with its re-expression causing p53/p21-dependent G1 arrest, downregulation of Rnd3 (suppressing migration via RhoA-ROCK), and regulation of VISTA, CXCR4, VEGF, and other downstream targets through direct promoter binding.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"FOXD3 is a forkhead/winged-helix transcription factor that acts predominantly as a context-dependent transcriptional repressor to maintain progenitor and pluripotent states and to restrict premature differentiation [#0, #4, #12]. In the early embryo it is required cell-autonomously for maintenance of pluripotent epiblast and for embryonic stem cell self-renewal and survival, functioning independently of Oct4, Sox2, and Nanog to suppress differentiation programs [#0, #4]. At the chromatin level FOXD3 operates as a dual-function enhancer regulator, recruiting the SWI/SNF ATPase BRG1 to open nucleosomes while simultaneously recruiting HDAC1/2 to limit enhancer activation, and during the transition from naive to primed pluripotency it decommissions naive and germline enhancers, after which FOXD3 must itself be silenced to license primordial germ cell specification [#20, #21]. FOXD3 is a core regulator of neural crest specification and multipotency: it is induced at the neural crest locus by CHD7/Oct3/4/Sox2/Nanog in a BMP/Wnt-dependent manner and through Pax7/Msx1-2/Ets1 and Zic1 enhancer inputs, acts jointly with tfap2a for neural crest induction, and lies genetically upstream of Slug, snai1b, and sox10 to maintain neural potential and survival while repressing mesenchymal and pigment-cell fates [#1, #3, #6, #9, #10, #24]. It directly represses the mitfa promoter to govern the melanophore-versus-iridophore and melanocyte-versus-Schwann-cell fate decisions [#13, #14, #11], and acts non-cell-autonomously in the Xenopus organizer to induce Nodal-related signals and dorsal mesoderm [#12]. In cancer, FOXD3 is re-induced upon attenuation of mutant B-RAF/MEK signaling in melanoma, where it drives p53/p21-dependent G1 arrest, represses the Rnd3-RhoA-ROCK migration axis through direct promoter binding, and confers tolerance to BRAF/MEK inhibitors [#5, #7, #8]; across other carcinomas it functions as a tumor suppressor through direct promoter activation of targets such as NDRG1, miR-137, and miR-214 and repression of EGFR-Ras-MEK-ERK signaling [#18, #19, #25, #26].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established where FOXD3 acts in the embryo by mapping its expression to premigratory/migrating neural crest and motor neuron progenitors, framing it as a candidate neural crest regulator.\",\n      \"evidence\": \"In situ hybridization and linkage mapping in mouse embryo\",\n      \"pmids\": [\"9767163\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Expression alone does not establish function\", \"No direct targets or binding sites defined\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrated FOXD3 is necessary and sufficient for neural crest determination and acts upstream of Slug, defining its position in the neural crest gene regulatory hierarchy.\",\n      \"evidence\": \"Xenopus gain/loss-of-function, dominant-negative construct, and Slug rescue epistasis\",\n      \"pmids\": [\"11493569\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct DNA targets not identified\", \"Molecular mechanism of repression vs activation not resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showed FOXD3 is required cell-autonomously for pluripotent epiblast maintenance, separating its role from initiation of the Oct4/Sox2 pluripotency program.\",\n      \"evidence\": \"Germline knockout mouse with chimera analysis and blastocyst culture\",\n      \"pmids\": [\"12381664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effectors of survival/self-renewal unknown\", \"Mechanism of repression at chromatin not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined FOXD3 as a transcriptional repressor that non-cell-autonomously induces mesoderm via Nodal-related signals, and as a direct transactivator of myf5, revealing context-dependent activator/repressor behavior.\",\n      \"evidence\": \"Xenopus repressor/activator fusion constructs with Nodal-inhibitor rescue; yeast one-hybrid plus luciferase and zebrafish morpholino epistasis for myf5\",\n      \"pmids\": [\"17092955\", \"16386728\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Co-factors mediating repressor vs activator switch not identified\", \"Direct Nodal-related target promoters not mapped\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Placed foxd3 upstream of snai1b and sox10 in neural crest specification while showing fate-selective requirement (neuronal/glial/cartilage but not melanocyte), refining its lineage-specific roles.\",\n      \"evidence\": \"Zebrafish forward-genetic sym1 mutant with expression analysis and TUNEL\",\n      \"pmids\": [\"16499899\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect regulation of snai1b/sox10 not distinguished\", \"Cause of lineage-selective apoptosis unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified mitfa as a direct repression target and embedded FOXD3 in an HDAC1\\u2192Foxd3\\u22a3Mitfa pathway controlling melanogenesis.\",\n      \"evidence\": \"Zebrafish hdac1 mutant with foxd3 morpholino rescue and chromatin association at the mitfa promoter\",\n      \"pmids\": [\"18068699\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Co-repressor complex at mitfa promoter not defined\", \"Mechanism of HDAC1 repression of foxd3 not detailed\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Distinguished FOXD3's ESC self-renewal/survival function from the core pluripotency factors, showing it represses differentiation and promotes survival independently of Oct4/Sox2/Nanog.\",\n      \"evidence\": \"Tamoxifen-inducible conditional knockout in ESCs with apoptosis, clonal self-renewal, and lineage marker assays\",\n      \"pmids\": [\"18653770\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct survival/differentiation target genes not yet identified\", \"Chromatin mechanism not addressed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Positioned Disc1 upstream of foxd3/sox10 in cranial neural crest migration, extending the regulatory inputs controlling FOXD3 levels.\",\n      \"evidence\": \"Zebrafish disc1 morpholino with live migration imaging and in situ hybridization\",\n      \"pmids\": [\"19570850\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect repression of foxd3 by Disc1 not shown\", \"Single-lab morpholino approach\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Established FOXD3 re-expression as a tumor-suppressive output of B-RAF/MEK inhibition in melanoma, causing p53/p21-dependent G1 arrest.\",\n      \"evidence\": \"siRNA, ectopic expression, MEK inhibitor treatment, and p53/p21 depletion rescue in mutant B-RAF melanoma cells\",\n      \"pmids\": [\"20332228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct FOXD3 targets driving p21 induction not mapped\", \"How B-RAF/MEK suppresses FOXD3 not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined a Foxd3/Mitfa transcriptional switch governing the bi-potent melanophore/iridophore fate decision from a common mitfa+ precursor.\",\n      \"evidence\": \"Zebrafish single/double mutant epistasis with photoconvertible EosFP lineage tracing\",\n      \"pmids\": [\"20460180\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct iridophore-program targets beyond pnp4a not defined\", \"Cofactors for fate switch unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed Foxd3 maintains cell-intrinsic neural crest multipotency by repressing mesenchymal/skeletal fates, and dissected its anti-migratory mechanism via direct repression of Rnd3-RhoA-ROCK in melanoma.\",\n      \"evidence\": \"Conditional NC-specific KO with clonal fate assays (mouse); ChIP at Rnd3 promoter with ROCK-inhibitor rescue (melanoma)\",\n      \"pmids\": [\"21228004\", \"21478267\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct mesenchymal-repression targets in NC not fully mapped\", \"Rnd3 work is single-lab Medium-confidence\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrated tfap2a and foxd3 are jointly necessary and sufficient for neural crest induction via modulation of Bmp/Wnt signaling, and that FOXD3 upregulation confers BRAF-inhibitor tolerance in melanoma.\",\n      \"evidence\": \"Zebrafish double-mutant analysis with pathway readouts; siRNA/overexpression with PLX4032/4720 cell-death assays in melanoma\",\n      \"pmids\": [\"21963426\", \"21996740\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which FOXD3 promotes drug tolerance not defined\", \"Direct Bmp/Wnt-pathway targets unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed Foxd3 and Pax3 cooperate in a dosage-sensitive manner for cardiac neural crest progenitor survival, defining a genetic partnership.\",\n      \"evidence\": \"Compound conditional Foxd3 KO with Pax3 heterozygosity, histology and apoptosis assays in mouse\",\n      \"pmids\": [\"21254333\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of Foxd3-Pax3 cooperation (physical vs genetic) not established\", \"Shared survival target genes unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Mapped the upstream enhancer logic controlling FoxD3 across neural crest subpopulations, showing distinct Pax7/Msx1-2/Ets1 (cranial NC1) and Zic1 (vagal/trunk NC2) inputs.\",\n      \"evidence\": \"Enhancer reporters, mutational analysis, in vivo ChIP, and morpholino epistasis in chick/Xenopus\",\n      \"pmids\": [\"23284303\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How distinct enhancer usage maps to functional output not resolved\", \"FOXD3's own targets in these subpopulations not addressed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrated Foxd3 controls melanocyte-vs-Schwann-cell and neuron-vs-glia fate switches, and acts as a context-dependent tumor suppressor in neuroblastoma via direct NDRG1 activation.\",\n      \"evidence\": \"Avian/mouse gain- and loss-of-function with lineage tracing; luciferase, ChIP, knockdown, and xenograft with NDRG1 rescue in neuroblastoma\",\n      \"pmids\": [\"23858437\", \"24269992\", \"24270162\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding for many ESC microarray targets unconfirmed\", \"NDRG1 work single-lab Medium-confidence\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Resolved the chromatin mechanism: FOXD3 dually recruits BRG1 (enhancer opening) and HDAC1/2 (activation restraint), and decommissions naive/germline enhancers to drive exit from naive pluripotency before being silenced for PGC specification.\",\n      \"evidence\": \"ChIP-seq, ATAC-seq, co-IP for BRG1 and HDAC1/2, RNA-seq, and conditional KO in ESCs and EpiSCs\",\n      \"pmids\": [\"26748757\", \"26748758\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"What dictates priming vs silencing at a given enhancer not fully defined\", \"Determinants of ESC vs EpiSC binding-site selection unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Mapped the regulatory network controlling and downstream of FoxD3 in neural crest stem cell formation, with CHD7/Oct3/4/Sox2/Nanog inducing FoxD3 in a BMP/Wnt-dependent manner and FoxD3 promoting Sox10.\",\n      \"evidence\": \"ChIP at FoxD3 regulatory regions, siRNA knockdown, and histone methyltransferase inhibition\",\n      \"pmids\": [\"27579714\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct FoxD3 occupancy at Sox10 not shown here\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Extended FOXD3's tumor-suppressive repressor role to direct activation of miR-137 (AKT2/mTOR) and miR-214 (MED19) and suppression of EGFR-Ras-MEK-ERK in carcinomas.\",\n      \"evidence\": \"ChIP/luciferase, knockdown/overexpression, EGFR inhibitor rescue, and xenografts in HCC, CRC, and colon cancer\",\n      \"pmids\": [\"24970808\", \"27811858\", \"27926503\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Each axis established in a single lab/cancer type\", \"Whether these reflect a unified mechanism vs context-specific outputs unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Linked FOXD3 to immune evasion by showing it regulates VISTA expression, with BRAF inhibition raising FOXD3 and lowering VISTA.\",\n      \"evidence\": \"siRNA, BRAF inhibitor treatment, in vivo tumor growth, and flow cytometry of immune infiltrate in melanoma\",\n      \"pmids\": [\"31940493\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct FOXD3 binding at the VISTA promoter not demonstrated\", \"Single-lab study\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how a single forkhead factor selects between repressing, priming, and activating distinct enhancers/promoters across pluripotency, neural crest, and cancer contexts, and which cofactors dictate this switch genome-wide.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model of cofactor-determined activator/repressor switching\", \"Determinants of cell-type-specific binding-site selection unresolved\", \"Direct human disease-causing mutation not identified in the corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 12, 20, 21, 13, 18, 25]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [8, 13, 16, 18, 25, 10]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [20, 13, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 3, 6, 9, 11, 12]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [13, 16, 18, 20, 25]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [20, 21]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 7, 8, 18, 26, 27]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"BRG1\", \"HDAC1\", \"HDAC2\", \"PAX3\", \"TFAP2A\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}